Canadian Centre on Substance Use and Addiction Evidence. Engagement. Impact.
Canadian Centre on Substance Use and Addiction

TEST PAGE: MOCKUP 2

Join Us!

Thank you for your interest in joining the CCSA team. Use the links below to view specific topics on this page.

Current Openings

We are currently looking for qualified individuals to join our team in Ottawa. Apply today!

Selection Process

Consideration of candidates for current opportunities begins immediately upon receipt of resumes and continues until we find the successful candidate. Due to the volume of applicants, we only contact candidates selected for an interview.

We welcome applications from people with disabilities. Accommodations for candidates with disabilities are available upon request during all aspects of the selection process.


Future Opportunities

We are always interested in receiving resumes from qualified and committed candidates. Let us know what future position you are interested in and submit your resume to hr@ccsa.ca. Thank you!
 

Who We Are

The Canadian Centre on Substance Use and Addiction (CCSA) brings together people and knowledge to improve the health and safety of individuals, families and communities across Canada. As a national non-profit created by an Act of Parliament, we hold a unique position from which we can bridge the gap between government agencies and public stakeholders.

The key to our success is teamwork and cross-sectoral collaboration. We are passionate people with strong values and a commitment to providing national leadership on substance use and addiction.

We believe in making a difference. At CCSA, we value our employees and believe in investing in them. If you are looking for a rewarding career in a fast-paced work environment with a highly engaged team, then apply to join us today!

CCSA embraces diversity and inclusivity in the workplace and is committed to achieving employment equity. Our goal is to attract, develop and retain highly talented employees from diverse backgrounds and encourage employees with accessibility needs to make their needs known.

We are committed to ensuring that Indigenous peoples and all equity seeking groups, including women, persons with disabilities, visible minorities, and members of the 2SLGBTQ+ community, are fully represented at all levels of our organization. We are also committed to identifying and working towards eliminating real or perceived racism and discrimination in our workplace.

Our Values

""

Social Responsibility

CCSA is dedicated to enriching the health and well-being of society.

""

Partnerships and
Collaboration

CCSA is dedicated to creating and nurturing partnerships to mobilize efforts, committed to inclusivity and building consensus, and focused on realizing a collective impact.

""

Cultivate Knowledge
and Strive for
Objectivity

""

Integrity and Respect

""

Excellence

Equity, Diversity and
Inclusion

 

What We Offer

At CCSA, we take the time to celebrate the important things. All employees enjoy:

  • A diverse and inclusive work environment
  • Comprehensive health and wellness programs, including nutrition, financial wellness and group meditation
  • Flexible hours to promote a healthy work–life balance
  • An employee-led social committee that organizes themed events
  • Team-building activities
  • Staff Charities Committee – organizes fundraising events and donations to local charities since 2002

Our Senior Leadership Team is committed to promoting psychological health and safety, which is reflected in our policies and programs, including numerous health and wellness initiatives.


Benefits

Permanent employees receive comprehensive benefits to meet their diverse needs. Our benefits plan includes:

  • Competitive paid time off, including vacation and personal leave
  • Comprehensive health and dental benefits, including a healthcare spending account
  • Employer contributed group RRSP plan
  • Professional development and training opportunities
  • Employee Assistance Plan providing support from a variety of specialists to help employees with personal or work-related issues
  • Long service awards
Academic Publications
Federal, Provincial and Territorial Policies and Guides
Professional Policies and Guides
Resource Collections

Academic Publications

Resource Organization
Home delivery of legal intoxicants in the age of COVID‐19 Addiction
Association of the COVID‐19 lockdown with smoking, drinking and attempts to quit in England: an analysis of 2019–20 data Addiction
Home delivery of legal intoxicants in the age of COVID‐19 Addiction
Optimizing Medication Treatment of Opioid Use Disorder During COVID-19 (SARS-CoV-2) Addiction
Mitigating and learning from the impact of COVID‐19 infection on addictive disorders Addiction
Substance use and abuse, COVID-19-related distress, and disregard for social distancing: A network analysis Addictive Behaviors
Substance use and abuse, COVID-19-related distress, and disregard for social distancing: A network analysis Addictive Behaviors
Changes in alcohol use as a function of psychological distress and social support following COVID-19 related University closings Addictive Behaviors
Substance use and abuse associated with the behavioral immune system during COVID-19: The special case of healthcare workers and essential workers Addictive Behaviors
Drinking to cope with the pandemic: The unique associations of COVID-19-related perceived threat and psychological distress to drinking behaviors in American men and women Addictive Behaviors
Study Results: In a Small Sample of Individuals with SUD, Many Are Hesitant to Receive Vaccine Addiction Policy Forum
Adapting Substance Use Treatment for HIV Affected Communities During COVID-19: Comparisons Between a Sexually Transmitted Infections (STI) Clinic and a Local Community Based Organization AIDS and Behavior
Rapid Implementation of Service Delivery Changes to Mitigate COVID-19 and Maintain Access to Methadone Among Persons with and at High-Risk for HIV in an Opioid Treatment Program AIDS and Behavior
Alcohol use disorder: A pre-existing condition for COVID-19? Alcohol
Are Patients With Alcohol Use Disorders at Increased Risk for Covid-19 Infection? Alcohol and Alcoholism
Complicated Alcohol Withdrawal—An Unintended Consequence of COVID-19 Lockdown Alcohol and Alcoholism
Drinking to Cope During COVID‐19 Pandemic: The Role of External and Internal Factors in Coping Motive Pathways to Alcohol Use, Solitary Drinking, and Alcohol Problems Alcoholism: Clinical and Experimental Research
Brief Report: The Impact of COVID‐19 on Emergency Department Overdose Diagnoses and County Overdose Deaths American Journal on Addictions
Editorial: Challenges to Opioid Use Disorders During COVID-19 American Journal of Addictions
Screening and brief intervention for substance use disorders in times of COVID-19: potential opportunities, adaptations, and challenges American Journal of Drug and Alcohol Abuse 
High-Risk Drinking in Midlife Before Versus During the COVID-19 Crisis: Longitudinal Evidence From the United Kingdom American Journal of Preventive Medicine
Leveraging Telehealth in the United States to Increase Access to Opioid Use Disorder Treatment in Pregnancy and Postpartum During the COVID-19 Pandemic American Journal of Psychiatry
Unintended consequences of the transition to telehealth for pregnancies complicated by opioid use disorder during the coronavirus disease 2019 pandemic American Journal of Obstetrics and Gynecology
Caring for patients with pain during the COVID-19 pandemic: consensus recommendations from an international expert panel Anaesthesia
When Epidemics Collide: Coronavirus Disease 2019 (COVID-19) and the Opioid Crisis Annals of Internal Medicine
Collision of the COVID-19 and Addiction Epidemics Annals of Internal Medicine
An Epidemic in the Midst of a Pandemic: Opioid Use Disorder and COVID-19 Annals of Internal Medicine
When Epidemics Collide: Coronavirus Disease 2019 (COVID-19) and the Opioid Crisis Annals of Internal Medicine
Relationship of substance dependence and time to RT-PCR negative status in patients with COVID-19 infection Asian Journal of Psychiatry
COVID-19 pandemic and addiction: Current problems and future concerns Asian Journal of Psychiatry
The US covid pandemic has a sinister shadow—drug overdoses BMJ
Association of the Covid-19 lockdown with smoking, drinking, and attempts to quit in England: an analysis of 2019-2020 data BMJ
Alcohol consumption and the COVID-19 pandemic : synthesizing knowledge for policy action Canadian Institutes of Health Research
A rapid review of opioid substitution therapy during major disruptions to medical care Canadian Institutes of Health Research
Don't forget our dual public health crises Canadian Journal of Emergency Medicine
Impacts of COVID-19 on Youth Mental Health, Substance Use, and Well-being: A Rapid Survey of Clinical and Community Samples Canadian Journal of Psychiatry
Is another public health crisis brewing beneath the COVID-19 pandemic? Canadian Journal of Public Health
Cannabinoids and the Coronavirus Cannabis and Cannabinoid Research
Substance use, mental health and weight-related behaviours during the COVID-19 pandemic in people with obesity Clinical Obesity
People Who Use Drugs Are Experiencing Overlapping Crises During COVID-19 CMAJ
COVID-19 and addiction Diabetes & Metabolic Syndrome: Clinical Research & Reviews
Socially-supportive norms and mutual aid of people who use opioids: An analysis of Reddit during the initial COVID-19 pandemic Drug and Alcohol Dependance
A glass half empty or a glass half full? Addressing the opioid crisis through the lens of COVID-19 Drug and Alcohol Dependence
Impacts of the COVID-19 pandemic on healthcare access among patients receiving medication for opioid use disorder Drug and Alcohol Dependence
Signal of increased opioid overdose during COVID-19 from emergency medical services data Drug and Alcohol Dependence
Overdose and risk factors for coronavirus disease 2019 Drug and Alcohol Dependence
COVID-19 vaccination among people who inject drugs: Leaving no one behind Drug and Alcohol Review
Describing the impact of the COVID‐19 pandemic on alcohol‐induced blackout tweets Drug and Alcohol Review
The burden of alcohol on health care during COVID‐19 Drug and Alcohol Review
COVID ‐19 and alcohol in Australia: Industry changes and public health impacts Drug and Alcohol Review
Illicit drug use and harms in Australia in the context of COVID ‐19 and associated restrictions: Anticipated consequences and initial response Drug and Alcohol Review
Alcohol use in times of the COVID 19: Implications for monitoring and policy Drug and Alcohol Review
Challenges of methadone maintenance treatment during the COVID-19 epidemic in China: policy and service recommendation European Neuropsychopharmacology
The impact of heroin illicit market in the framework of COVID 19 pandemic (Letter to the Editor) European Review for Medical and Pharmacological Sciences
Substance Use Disorders and COVID-19: Multi-Faceted Problems Which Require Multi-Pronged Solutions Frontiers in Psychiatry
Rapid evidence review of harm reduction interventions and messaging for people who inject drugs during pandemic events: implications for the ongoing COVID‑19 response Harm Reduction Journal
A national model of remote care for assessing and providing opioid agonist treatment during the COVID-19 pandemic: a report Harm Reduction Journal
Challenges in maintaining treatment services for people who use drugs during the COVID-19 pandemic Harm Reduction Journal
Relationships between Perceived Stress, Depression and Alcohol Use Disorders in University Students during the COVID-19 Pandemic: A Socio-Economic Dimension International Journal of Environmental Research and Public Health
Alcohol Consumption during the COVID-19 Pandemic: A Cross-Sectional Survey of US Adults International Journal of Environmental Research and Public Health
Evidence of increased Fentanyl use during the COVID-19 pandemic among opioid agonist treatment patients in Ontario, Canada International Journal of Drug Policy
Changes in substance supply and use characteristics among people who use drugs (PWUD) during the COVID-19 global pandemic: A national qualitative assessment in Canada International Journal of Drug Policy
A rapid review of the impacts of "Big Events" on risks, harms, and service delivery among people who use drugs: Implications for responding to COVID-19 International Journal of Drug Policy
An urgent impetus for action: safe inhalation interventions to reduce COVID-19 transmission and fatality risk among people who smoke crack cocaine in the United Kingdom International Journal of Drug Policy
Addressing co-occurring public health emergencies: The importance of naloxone distribution in the era of COVID-19 International Journal of Drug Policy
The perfect storm: COVID-19, mass incarceration and the opioid epidemic International Journal of Drug Policy
Why we should all be more careful in drawing conclusions about how COVID-19 is changing drug markets International Journal of Drug Policy
An urgent impetus for action: safe inhalation interventions to reduce COVID-19 transmission and fatality risk among people who smoke crack cocaine in the United Kingdom International Journal on Drug Policy
Online Gambling in the Midst of COVID-19: A Nexus of Mental Health Concerns, Substance Use and Financial Stress International Journal of Mental Health and Addiction
Addiction psychiatry and COVID-19: impact on patients and service provision Irish Journal of Psychological Medicine
Alcohol Withdrawal Rates in Hospitalized Patients During the COVID-19 Pandemic JAMA
Assessment of Filled Buprenorphine Prescriptions for Opioid Use Disorder During the Coronavirus Disease 2019 Pandemic JAMA Internal Medicine
Substance Use Disorder Linked to Higher COVID-19 Risk JAMA Network
Alcohol Withdrawal Rates in Hospitalized Patients During the COVID-19 Pandemic JAMA Network Open
Changes in Adult Alcohol Use and Consequences During the COVID-19 Pandemic in the US JAMA Network Open
Telehealth for Substance-Using Populations in the Age of Coronavirus Disease 2019: Recommendations to Enhance Adoption JAMA Psychiatry
Low Barrier Tele-Buprenorphine in the Time of COVID-19: A Case Report Journal of Addiction Medicine
Prevalence of Covid-19 Infection and Subsequent Cohorting in a Residential Substance Use Treatment Program in Boston, MA Journal of Addiction Medicine
Optimizing Medication Treatment of Opioid Use Disorder During COVID-19 (SARS-CoV-2) Journal of Addiction Medicine
What Does Adolescent Substance Use Look Like During the COVID-19 Pandemic? Examining Changes in Frequency, Social Contexts, and Pandemic-Related Predictors Journal of Adolescent Health
What Does Adolescent Substance Use Look Like During the COVID-19 Pandemic? Examining Changes in Frequency, Social Contexts, and Pandemic-Related Predictors Journal of Adolescent Health
Cannabis in the Time of Coronavirus Disease 2019: The Yin and Yang of the Endocannabinoid System in Immunocompetence The Journal of Alternative and Complementary Medicine
COVID-19 stress and substance use: Current issues and future preparations Journal of Anxiety Disorders
Problematic online gaming and the COVID-19 pandemic Journal of Behavioral Addictions
Alcohol and COVID-19: How Do We Respond to This Growing Public Health Crisis? Journal of General Internal Medicine
Challenges posed by COVID‐19 to people who inject drugs and lessons from other outbreaks Journal of the International AIDS Society
Clinical impact of COVID-19 on people with substance use disorders Journal of Public Health
COVID‐19 During the Opioid Epidemic – Exacerbation of Stigma and Vulnerabilities Journal of Rural Health
A Primary Care Response to COVID‐19 for Patients with an Opioid Use Disorder Journal of Rural Health
Alcohol Policy and Coronavirus: An Open Research Agenda Journal of Studies on Alcohol and Drugs
Telemedicine increases access to buprenorphine initiation during the COVID-19 pandemic Journal of Substance Abuse Treatment
Take-home dosing experiences among persons receiving methadone maintenance treatment during COVID-19 Journal of Substance Abuse Treatment
Leveraging digital tools to support recovery from substance use disorder during the COVID-19 pandemic response Journal of Substance Abuse Treatment
Depot buprenorphine during COVID-19 in Australia: Opportunities and challenges Journal of Substance Abuse Treatment
Sheltering in place and social distancing when the services provided are housing and social support: The COVID-19 health crisis and recovery housing Journal of Substance Abuse Treatment
Online digital recovery support services: An overview of the science and their potential to help individuals with substance use disorder during COVID-19 and beyond Journal of Substance Abuse Treatment
Medication treatment for opioid use disorder in the age of COVID-19: Can new regulations modify the opioid cascade? Journal of Substance Abuse Treatment
Increased flexibility in methadone take-home scheduling during the COVID-19 pandemic: Should this practice be incorporated into routine clinical care? Journal of Substance Abuse Treatment
Impacts of COVID-19 on residential treatment programs for substance use disorder Journal of Substance Abuse Treatment
Caring for women with substance use disorders through pregnancy and postpartum during the COVID-19 pandemic: Lessons learned from psychology trainees in an integrated OBGYN/substance use disorder outpatient treatment program Journal of Substance Abuse Treatment
Adaptations to jail-based buprenorphine treatment during the COVID-19 pandemic Journal of Substance Abuse Treatment
Adolescent substance use: Challenges and opportunities related to COVID-19 Journal of Substance Abuse Treatment
A commentary on the impact of COVID-19 on engagement of youth with substance use and co-occurring psychiatric disorders Journal of Substance Abuse Treatment
COVID-19-related treatment service disruptions among people with single- and polysubstance use concerns Journal of Substance Abuse Treatment
A clash of epidemics: Impact of the COVID-19 pandemic response on opioid overdose Journal of Substance Abuse Treatment
Youth OUD treatment during and after COVID: Increasing family involvement across the services continuum Journal of Substance Abuse Treatment
Providing addiction services during a pandemic: Lessons learned from COVID-19 Journal of Substance Abuse Treatment
Mobile van delivery of extended-release buprenorphine and extended-release naltrexone for youth with OUD: An adaptation to the COVID-19 emergency Journal of Substance Abuse Treatment
Revising our attitudes towards agonist medications and their diversion in a time of pandemic Journal of Substance Abuse Treatment
Commentary on the impact of the COVID-19 pandemic on opioid use disorder treatment among Indigenous communities in the United States and Canada Journal of Substance Abuse Treatment
COVID-19 and overdose prevention: Challenges and opportunities for clinical practice in housing settings Journal of Substance Abuse Treatment
Substance use disorder treatment, parenting, and COVID-19 Journal of Substance Abuse Treatment
A delicate compromise: Striking a balance between public safety measures and the psychosocial needs of staff and clients in residential substance use disorder treatment amid COVID-19 Journal of Substance Abuse Treatment
The use of mindfulness dialogue for life in substance use disorder treatment in the time of COVID-19 Journal of Substance Abuse Treatment
Telehealth sustains patient engagement in OUD treatment during COVID-19 Journal of Substance Abuse Treatment
Is necessity also the mother of implementation? COVID-19 and the implementation of evidence-based treatments for opioid use disorders Journal of Substance Abuse Treatment
With crisis comes opportunity: Unanticipated benefits resulting from pivots to take-home naloxone (THN) programs during the COVID-19 pandemic Journal of Substance Abuse Treatment
A Community Responds to the COVID-19 Pandemic: a Case Study in Protecting the Health and Human Rights of People Who Use Drugs Journal of Urban Health
Public health messaging and harm reduction in the time of COVID-19 The Lancet
COVID-19 Resource Centre  The Lancet
Alcohol use and misuse during the COVID-19 pandemic: a potential public health crisis? The Lancet
Drinking alone: COVID-19, lockdown, and alcohol-related harm The Lancet Gastroenterology & Hepatology
Public health messaging and harm reduction in the time of COVID-19 The Lancet Psychiatry
Innovative strategies to support physical distancing among individuals with active addiction The Lancet Psychiatry
Alcohol use and misuse during the COVID-19 pandemic: a potential public health crisis? The Lancet, Public Health
MCA Alcohol and Covid Free Webinar Medical Council on Alcohol
Alcohol advertisers may be using social media to encourage parents to drink during COVID‐19 Medical Journal of Australia
Alcohol consumption in the COVID-19 era Minerva Gastroenterologica e Dietologica
COVID-19 risk and outcomes in patients with substance use disorders: analyses from electronic health records in the United States Molecular Psychiatry
Addictions in the COVID-19 era: Current evidence, future perspectives a comprehensive review Morb Mortal Wkly Rep.
Review of opioid risk assessment tools with the growing need for telemedicine Pain Management
The Opioid Epidemic Within the COVID-19 Pandemic: Drug Testing in 2020 Population Health Management
Addictions in the COVID-19 era: Current evidence, future perspectives a comprehensive review Progress in Neuro-Psychopharmacology and Biological Psychiatry
Clinical Risk Factors for COVID-19 Among People With Substance Use Disorders Psychiatric Services
Alcohol dependence during COVID-19 lockdowns Psychiatry Research
The COVID-19 pandemic and its impact on substance use: Implications for prevention and treatment Psychiatry Research
Avoiding a new epidemic during a pandemic: The importance of assessing the risk of substance use disorders in the COVID-19 era Psychiatry Research
COVID19 pandemic and people with opioid use disorder: innovation to reduce risk Psychiatry Research
Preliminary indications of the burden of COVID-19 among people who inject drugs in England and Northern Ireland and the impact on access to health and harm reduction services Public Health
Substance misuse during COVID-19: protecting people who use drugs Public Health
Substance Use-Related Harms and Risk Factors during Periods of Disruption Public Health Ontario
Leveraging video telehealth for the transitional pain service in response to COVID-19 Regional Anesthesia and Pain Medicine
How is the COVID-19 pandemic changing our use of illegal drugs? An overview of ongoing research Society for the Study of Addiction
Canadians report lower self-perceived mental health during the COVID-19 pandemic Statistics Canada
Medication treatment for opioid use disorder and community pharmacy: Expanding care during a national epidemic and global pandemic Substance Abuse
Opioid use disorder and the COVID 19 pandemic: A call to sustain regulatory easements and further expand access to treatment Substance Abuse
Take home injectable opioids for opioid use disorder during and after the COVID-19 Pandemic is in urgent need: a case study Substance Abuse Treatment, Prevention, and Policy
A double-edged sword of using opioids and COVID-19: a toxicological view Substance Abuse Treatment, Prevention, and Policy
Shifts in Drug Use Behavior Among Electronic Dance Music Partygoers in New York During COVID-19 Social Distancing Substance Use & Misuse
COVID-19, jeux de hasard et d’argent : impacts, transformations et réflexions (in French only) Chaire de recherche sur l'étude du jeu, Université Concordia

Federal, Provincial and Territorial Policies and Guides

Resource Organization
CDSA Exemption and Interpretive Guide for Controlled Substances Health Canada
Exceptional importation & sale of drugs in relation to COVID-19: Tier 3 drug shortages Health Canada
Frequently Asked Questions: Subsection 56(1) Class Exemption for Patients, Practitioners and Pharmacists Prescribing and Providing Controlled Substances in Canada during the Coronavirus Pandemic Health Canada
Provincial/Territorial Class Exemptions for Supervised Consumption Site Operators Health Canada
Subsection 56(1) class exemption for patients, practitioners and pharmacists prescribing and providing controlled substances in Canada during the coronavirus pandemic Health Canada
In the time of COVID-19: Civil society statement on COVID-19 and people who use drugs International Drug Policy Consortium
Statement by the UN expert on the right to health on the protection of people who use drugs during the COVID-19 pandemic Office of the High Commissioner of Human Rights, United Nations
COVID-19 Guidance: Consumption and Treatment Services (CTS) Sites  Ontario Ministry of Health
COVID-19 Guidance for the Health Sector  Ontario Ministry of Health and Ministry of Long-Term Care

 

 

Professional Policies and Guides

Resource Organization
COVID-19: Information for Opioid Agonist Treatment Prescribers and Pharmacists  British Columbia Centre on Substance Use
Opioid Stewardship Under the New CDSA Exemptions (webinar) Canadian Pharmacists Association
Supporting people who use substances in acute care settings during the COVID-19 pandemic Canadian Research Initiative on Substance Misuse
Medications and other clinical approaches to support physical distancing for people who use substances during the COVID-19 pandemic Canadian Research Initiative on Substance Misuse
Strategies to Reduce SARS-CoV-2 Transmission in Supportive Recovery Programs and Residential Addiction Treatment Services Canadian Research Initiative on Substance Misuse
Harm reduction worker safety during the COVID-19 global pandemic Canadian Research Initiative on Substance Misuse
Early Guidance for Pharmacists in Managing Opioid Agonist Treatment during the COVID-19 Pandemic Centre for Addiction and Mental Health
Frequently Asked Questions: Subsection 56(1) Class Exemption for Patients, Practitioners and Pharmacists Prescribing and Providing Controlled Substances in Canada during the Coronavirus Pandemic Health Canada
CDSA Exemption and Interpretive Guide for Controlled Substances Health Canada
Clinical guide for the management of people with alcohol dependence during the coronavirus pandemic National Health Service, England
COVID-19: Working with vulnerable people Royal College of Psychiatrists, U.K.
A public health approach to withdrawal management in a pandemic Vancouver Coastal Health
Prescriber Guidelines for Risk Mitigation in the Context of Dual Public Health Emergencies Vancouver Coastal Health
Le traitement du trouble lié à l’utilisation d’opioïdes (TUO) (in French only) Collège des médecins du Québec
La pharmacothérapie de remplacement des substances psychoactives dans le contexte de pandémie de COVID-19 au Québec: Guide clinique à l’intention des prescripteurs (in French only) Institut universitaire sur les dépendances (IUD) du CIUSSS du Centre-Sud-de-l’Île-de-Montréal

Resource Collections

Resource Organization
COVID-19 Webinars Addictions Foundation of Manitoba
Substance Use and COVID-19 B.C. Centre on Substance Use
COVID-19 National Emergency Response California Bridge
COVID-19 Harm Reduction Resources  Canadian Drug Policy Coalition
COVID-19 Pandemic — National Rapid Guidance Canadian Research Initiative in Substance Misuse
Online resources of support for people with substance use disorders  Canadian Society of Addiction Medicine
Novel Coronavirus (COVID-19) (Information for the public, health professionals and community leaders)  First Nations Health Authority
COVID-19 Resources Foundation for Opioid Response Efforts
Resources for Safer Gambling During COVID-19 Gambling Research Exchange Ontario
Helping people who use substances during the COVID-19 pandemic Government of Canada
Resources for Canadians living with pain during COVID-19 Government of Canada
Wellness Together Canada: Mental Health and Substance Use Support Government of Canada
Health Canada Toolkit: COVID-19 and substance use Health Canada
COVID-19 printable materials, sector resources and webinar recordings Homelessness Services Association of BC
Coronavirus disease (COVID-19): Resources and information International Drug Policy Consortium (IDPC)
Resource Hub: Mental health and wellness during the COVID-19 pandemic Mental Health Commission of Canada
Coronavirus Disease (COVID-19) Resources NAADAC : The Association for Addictions Professionals
COVID-19 Harm Reduction COVID-19: Stay Home, Stay Safe New Zealand Drug Foundation
COVID-19 news and resources for people living with pain Pain BC
Synopsis of Key Articles – Coronavirus Disease 2019 (COVID-19) Public Health Ontario
Coronavirus (COVID-19) SAMHSA Resources and Information Substance Abuse and Mental Health Services Administration
COVID-19 Webinars Addictions Foundation of Manitoba
COVID-19 HIV Prevention, Treatment, Care and Support for People Who Use Drugs and People in Prison   United Nations Office on Drugs and Crime
Soutien clinique et organisationnel en dépendance et itinérance (in French only) Institut universitaire sur les dépendances

We use cookies to ensure that we give you the best experience possible on our website. 

You can change your cookie settings in your web browser at any time. If you continue without changing your settings, we’ll assume that you are happy to receive cookies from our website. Review our Privacy Notice for more information.